Strides Pharma Science Ltd (NSE:STAR)
ā‚¹ 748.25 31.6 (4.41%) Market Cap: 68.96 Bil Enterprise Value: 88.69 Bil PE Ratio: 28.29 PB Ratio: 2.88 GF Score: 76/100

Q2 2023 Strides Pharma Science Ltd Earnings Call Transcript

Nov 14, 2022 / 11:30AM GMT
Release Date Price: ā‚¹345 (+8.13%)
Operator

Ladies and gentlemen, good day, and welcome to the Strides Pharma Science Limited Q2 FY '23 Earnings Conference Call. (Operator Instructions). Please note that this conference is being recorded.

I now hand over the conference to Mr. Abhishek. Thank you, and over to you, sir.

Unidentified Company Representative

A very good evening, and thank you for joining us today for Strides earnings call for the second quarter and half year ended financial year 2023.

Today we have with us Arun, Founder, Executive Chairperson and Managing Director; Badree, Executive Director of Finance and Group CFO, to share the highlights with the business and financials for the quarter. I hope you've gone through our results release and the quarterly investor of today's presentation, which have been uploaded on our website as well as stock exchange website. The transcript of this call will be available in a week's time on our company's website.

Please note that today's discussion may be forward-looking in nature, and must be viewed in relation to risks pertaining to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot